fenofibrate has been researched along with Adenoma, Prostatic in 2 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Excerpt | Relevance | Reference |
|---|---|---|
| "The most common is benign prostatic hyperplasia (BPH)." | 5.48 | Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats. ( Refaie, MMM; Rifaai, RA; Zenhom, NM, 2018) |
| "The most common is benign prostatic hyperplasia (BPH)." | 1.48 | Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats. ( Refaie, MMM; Rifaai, RA; Zenhom, NM, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kortam, MA | 1 |
| Alawady, AS | 1 |
| Hamid Sadik, NA | 1 |
| Fathy, N | 1 |
| Refaie, MMM | 1 |
| Rifaai, RA | 1 |
| Zenhom, NM | 1 |
2 other studies available for fenofibrate and Adenoma, Prostatic
| Article | Year |
|---|---|
Fenofibrate mitigates testosterone induced benign prostatic hyperplasia via regulation of Akt/FOXO3a pathway and modulation of apoptosis and proliferation in rats.
Topics: Animals; Apoptosis; Cell Proliferation; Fenofibrate; Humans; Male; Prostatic Hyperplasia; Proto-Onco | 2022 |
Role of PPAR-α agonist fenofibrate in the treatment of induced benign prostatic hyperplasia with dysplastic changes in rats.
Topics: Animals; Antioxidants; Dihydrotestosterone; Fenofibrate; Glutathione Peroxidase; Male; Malondialdehy | 2018 |